Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.493NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.351.2 (Beta)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.640.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.352NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.251NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HC.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XCJNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FT.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.18NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.48NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.10NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EK.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.66NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.7NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GS.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.17NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-4751.81US
BA.1.21.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.39NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EE.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DV.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ES.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.41NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.19.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.479NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.437NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.371NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.4.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
FY.6.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HU.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.1.4.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KJ.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JC.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.625NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
HD.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
GY.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.411NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.109NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.361NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.177.38NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
A.12NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.417NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
AM.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.258.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.36.37NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.319NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.182NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used